4MO Role of ctDNA tumor fraction to select immunotherapy based regimens in advanced non-small cell lung cancer

{"title":"4MO Role of ctDNA tumor fraction to select immunotherapy based regimens in advanced non-small cell lung cancer","authors":"F.G. Dall'Olio , W.S. Zrafi , D. Vasseur , C.A. Garcia , K. Beshiri , A. Marinello , D. Planchard , L. Lacroix , F. Barlesi , E. Rouleau , A. Italiano , L. Pasquina , R. Madison , B. Besse","doi":"10.1016/j.iotech.2024.100888","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100888"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590018824001850","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}